Molly Henderson

2020 - UroGen Pharma Ltd.

In 2020, Molly Henderson earned a total compensation of $1.4M as Chief Financial Officer at UroGen Pharma Ltd..

Compensation breakdown

Bonus$100,000
Non-Equity Incentive Plan$69,875
Option Awards$787,994
Salary$94,269
Stock Awards$294,900
Other$15,192
Total$1,362,230

Henderson received $788K in option awards, accounting for 58% of the total pay in 2020.

Henderson also received $100K in bonus, $69.9K in non-equity incentive plan, $94.3K in salary, $294.9K in stock awards and $15.2K in other compensation.

Rankings

In 2020, Molly Henderson's compensation ranked 7,273rd out of 13,090 executives tracked by ExecPay. In other words, Henderson earned more than 44.4% of executives.

ClassificationRankingPercentile
All
7,273
out of 13,090
44th
Division
Manufacturing
3,040
out of 5,618
46th
Major group
Chemicals And Allied Products
1,226
out of 2,251
46th
Industry group
Drugs
1,059
out of 1,951
46th
Industry
Pharmaceutical Preparations
792
out of 1,456
46th

Pay ratio

Molly Henderson's Pay$1,362,230
Median Employee's Pay$222,109
Pay Ratio

6

to 1

In 2020, the annual total compensation of Molly Henderson was $1,362,230.

The annual total compensation of the median employee at UroGen Pharma Ltd. was $222,109.

The ratio of Molly Henderson's pay to the pay of median employee was therefore 6 to one.

Source: SEC filing on April 28, 2021.

Henderson's colleagues

We found five more compensation records of executives who worked with Molly Henderson at UroGen Pharma Ltd. in 2020.

2020

Elizabeth Barrett

UroGen Pharma Ltd.

Chief Executive Officer

2020

Jason Smith

UroGen Pharma Ltd.

General Counsel

2020

Peter Pfreundschuh

UroGen Pharma Ltd.

Chief Financial Officer

2020

Mark Schoenberg

UroGen Pharma Ltd.

Chief Medical Officer

2020

Stephen Mullennix

UroGen Pharma Ltd.

Chief Operating Officer

News

In-depth

You may also like